RNA sequencing results of treatment with BET inhibitor (JQ1) in human diffuse large B-cell lymphoma (DLBCL) cells based on Illumina HiSeq 2500 platform

High-throughput RNA sequencing Analysis of human diffuse large B-cell lymphoma (DLBCL) cells treated with BET inhibitor. Our study represents the detailed analysis of the more accurate quantitative and qualitative evaluation of mRNA content within DBLBC cells. Our study represents the detailed analysis of the more accurate quantitative and qualitative evaluation of mRNA content within DLBCL cells. Gene expression profiles in two DLBCL cell lines treated with JQ1 was generated by Illumina RNA sequencing and compared to profiles from DMSO-treated control cells.